| |
| Issue |
Title |
| |
| No 3 (2008) |
CLINICAL AND IMMUNOLOGIC IMPORTANCE OF MDR1/PGP 170 EXPRESSION IN PATIENTS WITH BREAST CANCER |
Abstract
PDF (Rus)
|
|
D. A. Yengay, I. V. Poddubnaya, N. N. Tupitsin, Ye. B. Mechetner |
| |
| No 4 (2008) |
IN VITRO EFFECTS OF CHEMICAL AGENTS ON BREAST TUMOR CELLS UNDER 24-HOUR INCUBATION |
Abstract
PDF (Rus)
|
|
S. N. Navruzov, L. T. Alimkhodzhayeva |
| |
| No 4 (2008) |
ANALYSIS OF THE RESULTS OF NEODJUVANT TREATMENT IN PATIENTS WITH CONSIDERATION FOR THE IMMUNOPHENOTYPICAL FEATURES OF BREAST CANCER |
Abstract
PDF (Rus)
|
|
A. A. Subbotina, V. P. Letyagin, N. N. Tupitsyn, I. V. Vysotskaya, V. D. Yermilova |
| |
| No 2 (2008) |
IMMUNOMORPHOLOGIC CHANGES IN TUMOR TISSUE OF PATIENTS WITH BREAST CANCER INDUCED BY NEOADJUVANT CHEMOTHERAPY CARRIED OUT IN ARTIFICIALLY HYPERGLYCEMIC STATE |
Abstract
PDF (Rus)
|
|
L. T. Alimkhodzhayeva |
| |
| No 2 (2008) |
INDICES OF FREE RADICAL PROCESSES AND ANTIOXIDANT SYSTEM IN TUMOR TISSUE AND PERIFOCAL ZONE IN DIFFERENT CLINICAL VARIANTS OF BREAST CANCER |
Abstract
PDF (Rus)
|
|
Ye. M. Frantziyantz, N. V. Soldatkina, L. A. Orlovskaya, A. V. Dashkov |
| |
| No 1 (2008) |
CLINICAL SIGNIFICANCE OF THE VEGFR-2 IN THE TUMORS AND BLOOD SERA OF THE BREAST CANCER PATIENTS |
Abstract
PDF (Rus)
|
|
E. A. Kim, A. M. Platova, I. V. Visotzkaya, E. S. Gershteyn, V. P. Letyagin, N. E. Kushlinskiy, E. E. Mironova |
| |
| No 3-4 (2009) |
MEMBRANE LEc EXPRESSION IN BREAST CANCER CELLS |
Abstract
PDF (Rus)
|
|
Ya. A. Udalova, N. V. Bovin, P. S. Obukhova, N. V. Shilova, A. M. Kovrigina, A. A. Subbotina, V. V. Timoshenko, O. E. Galanina, Z. G. Kadagidze, V. P. Letyagin, N. N. Tupitsyn |
| |
| No 3-4 (2009) |
DIAGNOSTIC VALUE OF STUDYING THE LEVELS OF PRO- AND ANTI-INFLAMMATORY CYTOKINES OF THE IMMUNE SYSTEM IN PATIENTS WITH BREAST CANCER |
Abstract
PDF (Rus)
|
|
L. T. Alimkhodjaeva |
| |
| No 3-4 (2009) |
CLINICAL PERSPECTIVES FOR STUDYING THE NUCLEAR TRANSCRIPTION FACTOR NF-κB IN BREAST CANCER |
Abstract
PDF (Rus)
|
|
E. S. Gershtein, A. M. Platova, V. P. Letyagin, N. E. Kushlinsky |
| |
| No 4 (2010) |
The status of epidermal growth factor receptor and topoisomerase IIα genes in triple-negative breast cancer cells |
Abstract
PDF (Rus)
|
|
D. A. Karseladze, I. V. Poddubnaya, A. I. Karseladze |
| |
| No 4 (2010) |
Cytofluorometric characteristics of molecular subtypes of breast cancer |
Abstract
PDF (Rus)
|
|
L. K. Tsoi, V. N. Bogatyrev, I. V. Vysotskaya, V. P. Letyagin, E. A. Kim |
| |
| No 2 (2010) |
New technologies and possibilities of breast cancer staging by the criterion N ex vivo |
Abstract
PDF (Rus)
|
|
Sh. Kh. Gantsev, M. G. Galeyev, R. Sh. Ishmuratova, D. S. Tursumetov, V. Yu. Tikhonova, A. V. Sultanbayev, Sh. M. Khusnutdinov, M. A. Tatunov, F. Sh. Zainullin |
| |
| No 2 (2010) |
The clinical value of p53 and the parameters of DNA-flow cytofluorometry in combination with clinical and morphological predictors in breast cancer |
Abstract
PDF (Rus)
|
|
L. K. Tsoi, V. N. Bogatyrev, V. P. Letyagin, Ya. V. Vishnevskaya, A. M. Platova |
| |
| No 1 (2010) |
The specific features of cellular, humoral, and activation markers of the immune system and the biophysical parameters of superficial peripheral lymphocyte membranes in patients with breast cancer |
Abstract
PDF (Rus)
|
|
L. T. Alimkhodzhayeva, A. D. Zikiryakhodzhayev |
| |
| No 1 (2010) |
Changes in angiogenesis markers during neoadjuvant treatment for locally advanced breast cancer |
Abstract
PDF (Rus)
|
|
E. A. Kim, I. V. Vysotskaya, N. E. Kushlinsky, V. P. Letyagin, E. S. Gershtein |
| |
| No 4 (2011) |
Time course of changes in the biochemical composition of peripheral lymph in breast cancer |
Abstract
PDF (Rus)
|
|
Sh. Kh. Gantsev, A. V. Sultanbayev, R. Sh. Ishmuratova, V. Yu. Frolova, Sh. R. Kzyrgalin |
| |
| No 4 (2011) |
Intraductal papillomas of the breast. The problems of the pathogenesis, treatment, and prevention of intraductal carcinoma |
Abstract
PDF (Rus)
|
|
G. Kh. Khanafiyev, S. A. Berzin, U. Yu. Maltseva, A. E. Mazur |
| |
| No 2 (2011) |
Time course of changes in 6-sulfatoxymelatonin excretion in patients with breast cancer after various neoadjuvant chemotherapy options |
Abstract
PDF (Rus)
|
|
Yu. S. Sidorenko, O. I. Kit, A. E. Lisutin, O. M. Semiletkin |
| |
| 1 - 18 of 18 Items |
|
